INTRODUCTION
In patients with coronary artery disease (CAD), the most important factors regarding to both symptoms and outcomes are the presence and extent of inducible ischemia.[1] Alleviation of ischemia with percutaneous coronary intervention (PCI) can improve symptoms and clinical outcomes. Stenting ischemic stenosis result in effective and durable relief of angina pectoris and improves outcome, while in opposite, stenting nonischemic stenosis deteriorates outcomes and is not cost-effective.[2,3,4]
INVASIVE FRACTIONAL FLOW RESERVE
Fractional flow reserve (FFR) has emerged as a useful tool to determine the lesions that require revascularization and is now considered as the gold standard for invasive assessment of ischemia.[5,6] FFR-guided therapy was shown to reduce major harmful cardiac events by approximately 28% compared with angiography-guided PCI[7] and by 68% compared with optimal medical therapy alone,[8] which is also cost effective.[9] Measurement of FFR during invasive angiography was upgraded to an IA classification in multi-vessel PCI from the European Society of Cardiology for identifying hemodynamically significant coronary lesions when noninvasive evidence of myocardial ischemia is unavailable.[5]
Numerous specific merits making FFR particularly suitable for the functional assessment of coronary stenosis and subsequent clinical decision-making, but the disadvantage should also be noted [Table 1].[5,6,10] To overcome the limitations of invasive measurement of FFR, researchers have developed noninvasive measurements of FFR derived from coronary computed tomographic angiography (CTA) (FFRCT), angiography, and optical coherence tomography (OCT).
Table 1.
Comparisons of invasive FFR and noninvasive FFR
| Comparisons | Advantages | Disadvantages |
|---|---|---|
| Invasive FFR | Unequivocally normal value of 1 | Potential hazard of plaque rupture |
| Independent of gender and various cardiovascular condition[5,6,10] | Expensive, time-consuming and allergic actions | |
| Well-validated in multi-vessel disease, previous myocardial infarction, and left main disease[11] | Can not reflect the morphology change in lesion | |
| Easy, rapid, and safe procedure in the catheterization laboratory | Not practical to re-evaluate FFR data in case of angiographic follow-up | |
| FFRCT | No need for modification of acquisition protocols and additional imaging[12] | Impaired coronary CT image quality with numerous artifacts |
| Combined anatomic and physiologic assessment in a single noninvasive test | CTA is limited in the context of advanced and calcific CAD and in patients with irregular heart rhythm or motion artifact[19] | |
| Applicable to various common cardiovascular conditions[12] | Assumptions in the physiological models may affect assumed parameters such as fluid density and viscosity | |
| FFRQCA | No induction of hyperemic flow, and no hazard of passing an intracoronary wire | The accuracy and feasibility should be determined by multicenter robust studies before its use from bench to bedside[19] |
| May be superior to FFRCT without additional procedure time, equipment, training, cost[19] | ||
| Permits longitudinal assessment of the entire coronary vessel or even the entire coronary tree | ||
| FFROCT | Clarifies the roles of variables between anatomical and functional measurements of stenosis severity[31] | The diagnostic accuracy and meaningful cut-off value for stenting decisions is not defined yet |
FFROCT: FD-OCT derived FFR; FFRCT: FFR derived from computed tomographic angiography; FFR: Fractional flow reserve; FD-OCT: Frequency domain optical coherence tomography; QCA: Quantitative coronary angiography.
FRACTIONAL FLOW RESERVE DERIVED FROM COMPUTED TOMOGRAPHIC ANGIOGRAPHY
Computed tomographic angiography is a noninvasive anatomic test with favorable diagnostic performance with which we can identify anatomically obstructive coronary stenosis.[12] Recent progress in computational fluid dynamics (CFD) and image-based modeling, now allows determination of rest and hyperemic coronary flow and pressure from CTA scans, with no need for modification of acquisition protocols, additional imaging or administration of medications.[12] Thus, FFRCT was measured noninvasively based on these novel techniques. The scientific basis for FFRCT has been well-described in details by Taylor et al.,[12,13] and three procedures are required in the computation of FFR from coronary CT [Figure 1a].[12,14] The scientific basis are as follows: (1) The baseline coronary blood flow is proportional to myocardial oxygen demand at rest for calculation of total resting coronary blood flow relative to patient-specific myocardial mass that can be quantified on the CT scan; (2) The resistance of the microcirculatory vascular bed at rest is inversely proportional to the size of the feeding vessel; (3) The coronary microcirculation has a predictable vasodilatory response to adenosine.
Figure 1.

Calculation process of fractional flow reserve (FFR) derived from coronary computed tomographic (CT) angiography and virtual FFR. (a) Computation of FFR from coronary CT; (b) Computation of FFR from coronary angiography.
Most recently, prospective multicenter Diagnosis of Ischemia Causing Stenoses Obtained Via Noninvasive FFR study and the Determination of Fractional Flow Reserve by Anatomic CTA trial reported that FFRCT was demonstrated to be superior to measures of stenosis severity for determination of lesion-specific ischemia.[12,13,15] Noninvasive FFRCT demonstrated per-vessel accuracy, sensitivity, specificity positive predictive value (PPV), and negative predictive value (NPV) for lesions causing ischemia of 84.3%, 87.9%, 82.2%, 73.9%, and 92.2%, respectively and was found to be superior to CTA stenosis for diagnosing ischemic lesions which demonstrated an accuracy, sensitivity, specificity, PPV, and NPV of 58.5%, 91.4%, 39.6%, 46.5%, and 88.9%, respectively.[12,16] There was a marked improvement in the ability to discriminate ischemia-causing stenosis with an area under the curve in the receiver operating characteristics curve of 0.95 for FFRCT (P < 0.0001 compared to CT alone).[17] This promising novel technology provides a combined anatomic and physiologic assessment of CAD in a single noninvasive test that can help select patients for invasive angiography and revascularization or best medical therapy. The recent landmark ABSORB[18] trial first selects FFRCT as the functional parameter to evaluate coronary stenosis severity instead of invasive FFR.[19,20]
Nevertheless, the diagnostic performance of FFRCT may be influenced by many potential limitations [Table 1]. As for image quality, however, closely adherence to coronary CTA image acquisition guidelines, particularly by use of beta-blockers to reduce heart rate and heart rate variability and administration of sublingual nitrates to dilate the coronary arteries can minimize artifacts.[13,21] In conclusion, the validation of FFRCT is very impressive, and this supernova is full of expectations in the future clinical research.
FRACTIONAL FLOW RESERVE DERIVED FROM ANGIOGRAPHY
Meanwhile, three group of researchers also developed noninvasive measurement of FFR from angiography data alone. In 1996, Molloi et al.[22] developed the first-pass analysis technique to calculate the blood flow through the signal strength of CAG. Computed from blood flow, they successfully assessed FFR based on angiography data (FFRa) on swine models.[23] The first-pass analysis technique can be used to measure absolute coronary blood flow by analyzing the propagation of a contrast material signal in the coronary system.[22,24,25] The volume of the vascular bed supplied by a particular coronary artery is modeled as a container with a single input without any assumptions about the internal structure of the vascular bed or the nature of exit conduits. In the period of the cardiac cycle, coronary blood flow was reflected with the change in contrast volume. Power injection of contrast material was assumed to substitute for blood with contrast material. Since the concentration of iodine in the contrast material and a linear regression analysis between measured integrated gray levels and iodine massed in the calibration phantom were known, it is possible to convert gray level to volume using the calibration curve and the known iodine concentration of the contrast material.[14,22] In this way, the difference in densitometric signal in the vascular bed can be converted to the volume of contrast material entering the vascular bed between successive images using system iodine calibration.[26] In order to measure FFRa, the ratio of blood flow under condition of a stenosis (QS) to theoretically normal blood flow (QN) was calculated. On the assumption that blood was momentarily replaced with contrast material, QS was acquired using a time-density curve and QN was calculated with the total coronary arterial volume using scaling laws.[19] However, the accuracy of FFRa was limited by the small sample size of swines, and this technique required curb of breathing motion, which might significantly restrict the development in real practice.
Decades later, Morris et al.[1] used generic boundary conditions for CFD analysis to calculate virtual FFR (vFFR) in CAD patients undergoing rotational coronary angiography. In computing vFFR from angiographic images, four procedures are involved [Figure 1b]. It was indicated that CFD model predicted which lesions were physiologically significant (FFR < 0.80) with accuracy, sensitivity, specificity, PPV and NPV of 97%, 86%, 100%, 100%, and 97% respectively.[1] vFFR and pressure derived FFR values were compared. On average, the vFFR values deviated from FFR by ±0.06 (mean delta = 0.02, standard division = 0.08), so vFFR and FFR were closely correlated (r = 0.84).[1] It revealed that the FFR was reliably predicted without the need for invasive measurements or inducing hyperemia.
However, the interrogated lesions in Morris's study were simple lesions, and vFFR required over 24 h for the computation. Therefore, Tu et al.[27] developed a novel approach on the basis of three-dimensional (3D) quantitative coronary angiography (QCA) and thrombolysis in myocardial infarction (TIMI). Frame count for fast computation of FFR (FFRQCA) in CAD patients. In general, the strategy is to reconstruct anatomical models by 3D-QCA and subsequently apply CFD, using mean volumetric flow rate (VFR) at hyperemic derived by 3D-QCA and TIMI frame count at the boundaries. First, the contrast medium transport time was calculated at hyperemic by TIMI frame count. Then, VFR at hyperemia was derived using the lumen volume of reconstructed coronary tree divided by the mean transport time. Next, in CFD, instead of using generic boundary conditions, this study apply the VFR at hyperemic and the mean pressure at the guiding catheter tip at the inlet, and apply fully developed flow condition at the outlets, leading to a fast simulation approach. It revealed that good correlation (r = 0.81; P < 0.001), with a mean difference of (r = 0.81; P < 0.001) was found between FFRQCA and FFR.[27] What's more, FFRQCA was assessed to have overall accuracy, sensitivity, specificity, PPV, and NPV of 88%, 78%, 93%, 82%, and 91%, respectively.[27]
In conclusion, FFRQCA might be superior to pressure derived FFR and FFRCT [Table 1]. The primary difference between FFRQCA and FFRCT is that FFRCT use empiric flow derivation based on average population-based physiological model assumptions under rest conditions while FFRQCA uses individual hyperemic flow that better accounts for distal microvascular disease, providing a better approximation of invasive measures overall.[28]
FRACTIONAL FLOW RESERVE DERIVED FROM OPTICAL COHERENCE TOMOGRAPHY
Most recently, it was suggested that vFFR could also be noninvasively calculated by frequency domain OCT (FD-OCT). FD-OCT merges to be another novel noninvasive method for the quantitative measure of stenosis severity, which provides cross-sectional images of coronary arteries and deployed stents with micron resolution and measures lumen dimensions with excellent reproducibility.[29,30] It also provides information about plaque vulnerability, calcification, estimates the blood flow resistance and microvascular resistance of the vessel segments imaged. Through the volumetric analysis of FD-OCT images, FFR was calculated from the blood flow resistance and the microvascular resistance.[31] Combined with a blood flow resistances model, it can overcome many limitations of conventional measures of stenosis severity based on QCA. FD-OCT derived FFR (FFROCT), showed a significant correlation with pressure derived FFR.[31] Zafar et al. calculated FFROCT with microvascular resistance under maximal hyperemia (Rmv), blood flow resistance of the stenosis (Rs), and the blood flow resistance of the length of vessel outside the imaged segment (Re). FFR was calculated as (Rmv + Re)/(Rmv + Re + Rs) with Rmv measured by dividing the hyperemic microvascular resistance index and Re calculated as the viscous flow resistance of the length of vessel outside the imaged segment using Poiseuille's law.[31] Rs that is assumed to consist of a flow independent component that results from vicious and kinetic losses, and a result is calculated using the analytical method.
Stefano et al.[32] were the first to determine the correlation between FFR and OCT derived lumen measurements in 14 patients with 18 stenosis, but no significant correlation between FFR and the OCT measured minimum lumen area (MLA) (r = 0.167, P = 0.56), minimum lumen diameter (MLD) (r = −0.42, P = 0.13), and percent area stenosis (%AS) (r = 0.29, P = 0.29) was found. Recently, Gonzalo et al.[33] evaluated the diagnostic efficiency of OCT derived lumen measurements identifying the stenosis severity in 56 patients with 61 stenoses and reported poor but significant correlation between FFR and OCT measured MLA (r = 0.51, P < 0.001), MLD (r = 0.4, P = 0.005), and %AS (r = 0.33, P = 0.02). Zafar et al.[31] carried out a feasibility study enrolled 20 patients to figure out the relationship between pressure-derived FFR and FFROCT. A moderate but significant correlation between pressure derived FFR and FFROCT (r = 0.69, P < 0.001) was detected, and Bland–Altman analysis showed that the mean differences between FFR and FFROCT were 0.05 ± 0.14 (limits of agreement: −0.09–0.19).[31]
Frequency domain optical coherence tomography is a promising tool in assessing stenotic lesions. Firstly, since no clear guidelines on how to manage multiple lesions with a positive FFR in the distal segment, FD-OCT is important to identify the noncritical MLA in the proximal stenosis, leading to selective intervention of the distal stenosis and optimization of the stent deployment procedure.[32]
Secondly, FD-OCT also has a positive effect under the conditions of acute coronary syndromes and negative FFR to evaluate any feature of plaque instability. However, since a meaningful cut-off value for stenting decisions is not driven yet, FFROCT may not be considered in primary stenting decisions. With further validation, FFROCT has the potential to become a valuable tool for the evaluation of coronary artery stenosis and may play a role in interventional procedural planning and decision-making.
PERSPECTIVE
In summary, FFRCT, FFRQCA and FFROCT have their own advantages and limitations respectively. It displays a significant superiority of the traditional invasive one and may be a potential diagnostic tool for lesion-specific ischemia and help to make optimal clinical decisions. However, the Newland discovered by Columbus needs hundreds of followers to create the prosperity. Therefore, these noninvasive assessment techniques of coronary FFR should be under exploiting.
Footnotes
Edited by: Jian Gao and Li-Shao Guo
Source of Support: Nil.
Conflict of Interest: None declared.
REFERENCES
- 1.Morris PD, Ryan D, Morton AC, Lycett R, Lawford PV, Hose DR, et al. Virtual fractional flow reserve from coronary angiography: Modeling the significance of coronary lesions: Results from the VIRTU-1 (VIRTUal Fractional Flow Reserve From Coronary Angiography) study. JACC Cardiovasc Interv. 2013;6:149–57. doi: 10.1016/j.jcin.2012.08.024. [DOI] [PubMed] [Google Scholar]
- 2.Pijls NH, Tanaka N, Fearon WF. Functional assessment of coronary stenoses: Can we live without it? Eur Heart J. 2013;34:1335–44. doi: 10.1093/eurheartj/ehs436. [DOI] [PubMed] [Google Scholar]
- 3.Moses JW, Stone GW, Nikolsky E, Mintz GS, Dangas G, Grube E, et al. Drug-eluting stents in the treatment of intermediate lesions: Pooled analysis from four randomized trials. J Am Coll Cardiol. 2006;47:2164–71. doi: 10.1016/j.jacc.2006.01.068. [DOI] [PubMed] [Google Scholar]
- 4.Teirstein PS. The dueling hazards of incomplete revascularization and incomplete data. Circulation. 2006;113:2380–2. doi: 10.1161/CIRCULATIONAHA.106.623140. [DOI] [PubMed] [Google Scholar]
- 5.Lotfi A, Jeremias A, Fearon WF, Feldman MD, Mehran R, Messenger JC, et al. Expert consensus statement on the use of fractional flow reserve, intravascular ultrasound, and optical coherence tomography: A consensus statement of the Society of Cardiovascular Angiography and Interventions. Catheter Cardiovasc Interv. 2014;83:509–18. doi: 10.1002/ccd.25222. [DOI] [PubMed] [Google Scholar]
- 6.Elgendy IY, Conti CR, Bavry AA. Fractional flow reserve: An updated review. Clin Cardiol. 2014;37:371–80. doi: 10.1002/clc.22273. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Pijls NH, Fearon WF, Tonino PA, Siebert U, Ikeno F, Bornschein B, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study. J Am Coll Cardiol. 2010;56:177–84. doi: 10.1016/j.jacc.2010.04.012. [DOI] [PubMed] [Google Scholar]
- 8.De Bruyne B, Pijls NH, Kalesan B, Barbato E, Tonino PA, Piroth Z, et al. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med. 2012;367:991–1001. doi: 10.1056/NEJMoa1205361. [DOI] [PubMed] [Google Scholar]
- 9.Pyxaras SA, Tu S, Barbato E, Wyffels E, Reiber JH, Wijns W. Co-registration of fractional flow reserve and optical coherence tomography with the use of a three-dimensional angiographic roadmap: An opportunity for optimisation of complex percutaneous coronary interventions. EuroIntervention. 2013;9:889. doi: 10.4244/EIJV9I7A146. [DOI] [PubMed] [Google Scholar]
- 10.de Bruyne B, Bartunek J, Sys SU, Pijls NH, Heyndrickx GR, Wijns W. Simultaneous coronary pressure and flow velocity measurements in humans. Feasibility, reproducibility, and hemodynamic dependence of coronary flow velocity reserve, hyperemic flow versus pressure slope index, and fractional flow reserve. Circulation. 1996;94:1842–9. doi: 10.1161/01.cir.94.8.1842. [DOI] [PubMed] [Google Scholar]
- 11.Hamilos M, Peace A, Kochiadakis G, Skalidis E, Ntalianis A, De Bruyne B, et al. Fractional flow reserve: An indispensable diagnostic tool in the cardiac catheterisation laboratory. Hellenic J Cardiol. 2010;51:133–41. [PubMed] [Google Scholar]
- 12.Taylor CA, Fonte TA, Min JK. Computational fluid dynamics applied to cardiac computed tomography for noninvasive quantification of fractional flow reserve: Scientific basis. J Am Coll Cardiol. 2013;61:2233–41. doi: 10.1016/j.jacc.2012.11.083. [DOI] [PubMed] [Google Scholar]
- 13.Zarins CK, Taylor CA, Min JK. Computed fractional flow reserve (FFTCT) derived from coronary CT angiography. J Cardiovasc Transl Res. 2013;6:708–14. doi: 10.1007/s12265-013-9498-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Lansky AJ, Pietras C. Fractional flow reserve from 3-dimensional quantitative coronary angiography: Fresh light through an old window. JACC Cardiovasc Interv. 2014;7:778–80. doi: 10.1016/j.jcin.2014.05.002. [DOI] [PubMed] [Google Scholar]
- 15.Min JK, Leipsic J, Pencina MJ, Berman DS, Koo BK, van Mieghem C, et al. Diagnostic accuracy of fractional flow reserve from anatomic CT angiography. JAMA. 2012;308:1237–45. doi: 10.1001/2012.jama.11274. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Leipsic J, Yang TH, Thompson A, Koo BK, Mancini GB, Taylor C, et al. CT angiography (CTA) and diagnostic performance of noninvasive fractional flow reserve: Results from the Determination of Fractional Flow Reserve by Anatomic CTA (DeFACTO) study. AJR Am J Roentgenol. 2014;202:989–94. doi: 10.2214/AJR.13.11441. [DOI] [PubMed] [Google Scholar]
- 17.Min JK, Koo BK, Erglis A, Doh JH, Daniels DV, Jegere S, et al. Usefulness of noninvasive fractional flow reserve computed from coronary computed tomographic angiograms for intermediate stenoses confirmed by quantitative coronary angiography. Am J Cardiol. 2012;110:971–6. doi: 10.1016/j.amjcard.2012.05.033. [DOI] [PubMed] [Google Scholar]
- 18.Nieman K, Serruys PW, Onuma Y, van Geuns RJ, Garcia-Garcia HM, de Bruyne B, et al. Multislice computed tomography angiography for noninvasive assessment of the 18-month performance of a novel radiolucent bioresorbable vascular scaffolding device: The ABSORB trial (a clinical evaluation of the bioabsorbable everolimus eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions) J Am Coll Cardiol. 2013;62:1813–4. doi: 10.1016/j.jacc.2013.07.030. [DOI] [PubMed] [Google Scholar]
- 19.Fan G, Qi X, Yang C, Fu Q. Virtual fractional flow reserve derived from invasive coronary angiography. Catheter Cardiovasc Interv. 2014;84:E16–7. doi: 10.1002/ccd.25223. [DOI] [PubMed] [Google Scholar]
- 20.Qi X, Fan G, Zhou L, Yang C. Clinical implication landmark: Noninvasive quantification of fractional flow reserve evaluating interventional therapy. Catheter Cardiovasc Interv. 2014;83:334–5. doi: 10.1002/ccd.25195. [DOI] [PubMed] [Google Scholar]
- 21.Abbara S, Arbab-Zadeh A, Callister TQ, Desai MY, Mamuya W, Thomson L, et al. SCCT guidelines for performance of coronary computed tomographic angiography: A report of the Society of Cardiovascular Computed Tomography Guidelines Committee. J Cardiovasc Comput Tomogr. 2009;3:190–204. doi: 10.1016/j.jcct.2009.03.004. [DOI] [PubMed] [Google Scholar]
- 22.Molloi S, Ersahin A, Tang J, Hicks J, Leung CY. Quantification of volumetric coronary blood flow with dual-energy digital subtraction angiography. Circulation. 1996;93:1919–27. doi: 10.1161/01.cir.93.10.1919. [DOI] [PubMed] [Google Scholar]
- 23.Zhang Z, Takarada S, Molloi S. Quantification of absolute coronary flow reserve and relative fractional flow reserve in a swine animal model using angiographic image data. Am J Physiol Heart Circ Physiol. 2012;303:H401–10. doi: 10.1152/ajpheart.00153.2012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Molloi S, Kassab GS, Zhou Y. Quantification of coronary artery lumen volume by digital angiography: In vivo validation. Circulation. 2001;104:2351–7. doi: 10.1161/hc4401.098435. [DOI] [PubMed] [Google Scholar]
- 25.Molloi S, Bednarz G, Tang J, Zhou Y, Mathur T. Absolute volumetric coronary blood flow measurement with digital subtraction angiography. Int J Card Imaging. 1998;14:137–45. doi: 10.1023/a:1006059709539. [DOI] [PubMed] [Google Scholar]
- 26.Takarada S, Zhang Z, Molloi S. An angiographic technique for coronary fractional flow reserve measurement: In vivo validation. Int J Cardiovasc Imaging. 2013;29:535–44. doi: 10.1007/s10554-012-0119-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Tu S, Barbato E, Köszegi Z, Yang J, Sun Z, Holm NR, et al. Fractional flow reserve calculation from 3-dimensional quantitative coronary angiography and TIMI frame count: A fast computer model to quantify the functional significance of moderately obstructed coronary arteries. JACC Cardiovasc Interv. 2014;7:768–77. doi: 10.1016/j.jcin.2014.03.004. [DOI] [PubMed] [Google Scholar]
- 28.Nakazato R, Park HB, Berman DS, Gransar H, Koo BK, Erglis A, et al. Noninvasive fractional flow reserve derived from computed tomography angiography for coronary lesions of intermediate stenosis severity: Results from the DeFACTO study. Circ Cardiovasc Imaging. 2013;6:881–9. doi: 10.1161/CIRCIMAGING.113.000297. [DOI] [PubMed] [Google Scholar]
- 29.Gonzalo N, Garcia-Garcia HM, Serruys PW, Commissaris KH, Bezerra H, Gobbens P, et al. Reproducibility of quantitative optical coherence tomography for stent analysis. EuroIntervention. 2009;5:224–32. doi: 10.4244/eijv5i2a35. [DOI] [PubMed] [Google Scholar]
- 30.Orii M, Kubo T, Tanaka A, Kitabata H, Ino Y, Shiono Y, et al. Inter-scan reproducibility of geometric coronary artery measurements using frequency-domain optical coherence tomography. Int Heart J. 2013;54:64–7. doi: 10.1536/ihj.54.64. [DOI] [PubMed] [Google Scholar]
- 31.Zafar H, Sharif F, Leahy MJ. Feasibility of intracoronary frequency domain optical coherence tomography derived fractional flow reserve for the assessment of coronary artery stenosis. Int Heart J. 2014;55:307–11. doi: 10.1536/ihj.13-362. [DOI] [PubMed] [Google Scholar]
- 32.Stefano GT, Bezerra HG, Attizzani G, Chamié D, Mehanna E, Yamamoto H, et al. Utilization of frequency domain optical coherence tomography and fractional flow reserve to assess intermediate coronary artery stenoses: Conciliating anatomic and physiologic information. Int J Cardiovasc Imaging. 2011;27:299–308. doi: 10.1007/s10554-011-9847-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Gonzalo N, Escaned J, Alfonso F, Nolte C, Rodriguez V, Jimenez-Quevedo P, et al. Morphometric assessment of coronary stenosis relevance with optical coherence tomography: A comparison with fractional flow reserve and intravascular ultrasound. J Am Coll Cardiol. 2012;59:1080–9. doi: 10.1016/j.jacc.2011.09.078. [DOI] [PubMed] [Google Scholar]
